Medicare Self-Injectable Drug Coverage Rule Expected By Spring
Executive Summary
The Centers for Medicare & Medicaid Services expects to issue a memorandum expanding Medicare coverage for self-injectable pharmaceuticals by spring
You may also be interested in...
CMS Medicare Self-Injectable Guidelines Maintain Split Within Drug Classes
The Centers for Medicare & Medicaid Services' self-injectables guidelines would still divide Medicare coverage within a therapeutic drug class based on route of administration
CMS Medicare Self-Injectable Guidelines Maintain Split Within Drug Classes
The Centers for Medicare & Medicaid Services' self-injectables guidelines would still divide Medicare coverage within a therapeutic drug class based on route of administration
Enbrel Shortage Strategies: Clinical Trials Will Provide “Bolus” Of Patients
Immunex' ongoing Enbrel clinical trials will help provide a "bolus" of patients for the rheumatoid arthritis agent once the company expands its commercial capacity for the biologic